Implementation Framework Guidance For Pre Exposure Prophylaxis Of Hiv Infection PDF Download

The Pre-Exposure Prophylaxis (PrEP) guidelines 2014, supported by scientific evidence, recommends the use of antiviral therapy (ART) prophylaxis to prevent human immunodeficiency virus (HIV) infection in patients at high-risk for HIV infection. The literature is limited on PrEP guidelines use in the urgent care (UC) settings. The purpose of this project was to determine the knowledge of urgent care providers regarding the PrEP guidelines and their practices of assess patients at high-risk for HIV infection. Additionally, the project aimed to determine the feasibility of providers to prescribe, implement and follow patients to whom they have prescribed the PrEP guidelines. The diffusion of innovation theory was used as the framework of this project to assist in process of the adoption of the PrEP in the urgent care settings. This project used quantitative descriptive methodology using a survey and chart review that identified the current HIV preventive practice in the UC in Arizona. There were four clinical questions (CQs) that investigated the healthcare provider's knowledge, practice, and attitude toward HIV prevention. There were 208 HIV screening tests ordered in 2016 in the UC, and there were 20 patients that received ART prophylaxis prescribed by nurse practitioner and from those, only six prescribed Truvada® were for PrEP. Truvada® was given to 2.88% of 208 of the patients screened for HIV. The project identified barriers to implementation of the PrEP guidelines in UC and the DIT can assist with diffusion of PrEP guidelines. The project identified algorithms to facilitate the application of prep guidelines into urgent care. The applicability of the PrEP guidelines into the UC settings was investigated and the UC is prepared to indicate ART to those who have clinical indications for PrEP, in addition to HIV screening and education.